Neurotoxicity evoked by organophosphates and available countermeasures

L Pulkrabkova, B Svobodova, J Konecny… - Archives of …, 2023 - Springer
Organophosphorus compounds (OP) are a constant problem, both in the military and in the
civilian field, not only in the form of acute poisoning but also for their long-lasting …

[HTML][HTML] Sleep disorder

B Karna, A Sankari, G Tatikonda - 2020 - europepmc.org
Objectives: Identify the etiology of sleep disorders. Describe the evaluation of sleep
disorders. Explain the management options available for sleep disorders. Summarize an …

The role of sleep in cognitive function: the value of a good night's rest

RR Gilley - Clinical EEG and Neuroscience, 2023 - journals.sagepub.com
As a universal, evolutionarily conserved phenomenon, sleep serves many roles, with an
integral role in memory. This interplay has been examined in a variety of research. The …

Effects of Japanese policies and novel hypnotics on long‐term prescriptions of hypnotics

M Takeshima, K Yoshizawa, M Enomoto… - Psychiatry and …, 2023 - Wiley Online Library
Aim The current study aimed to examine the effect of Japanese policies for appropriate
hypnotics use and novel hypnotics (eg melatonin receptor agonist and orexin receptor …

Potentially inappropriate medication use in patients with dementia

K Yoon, JT Kim, WG Kwack, D Kim, KT Lee… - International Journal of …, 2022 - mdpi.com
The objective of this study was to characterize the epidemiology of using potentially
inappropriate medications associated with dementia exacerbation (DPIMs) in elderly …

[HTML][HTML] Modified Suanzaoren decoction in treating post-stroke cognitive impairment with comorbid insomnia symptoms: A clinical trial

M Zhu, G Pan, F Luo, S Sui, Y Zhang - Medicine, 2023 - journals.lww.com
Background: Cognitive impairment and insomnia are common complications for stroke
patients, and often coexist without effective therapy. Modified Suanzaoren decoction (M …

[HTML][HTML] Sleep Disorders in Mild Cognitive Impairment

B Randhi, SD Gutlapalli, J Pu, MF Zaidi, M Patel… - Cureus, 2023 - ncbi.nlm.nih.gov
We have an increasingly aging population and, therefore, cognitive impairment and
dementia are becoming more common. Similarly, sleep disorders are also more common …

[HTML][HTML] Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseases

H Cortes-Flores, G Torrandell-Haro… - Frontiers in Psychiatry, 2024 - frontiersin.org
Objective As neuropsychiatric conditions can increase the risk of age-related
neurodegenerative diseases (NDDs), the impact of CNS-active drugs on the risk of …

Navigating the complex landscape of benzodiazepine-and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond

F Koniuszewski, FD Vogel, I Dajić, T Seidel… - Frontiers in …, 2023 - frontiersin.org
Introduction Medications which target benzodiazepine (BZD) binding sites of GABAA
receptors (GABAARs) have been in widespread use since the nineteen-sixties. They carry …

Use of antidepressant and anxiolytic drugs in Scandinavian countries between 2006 and 2021: A prescription database study

I Bojanić - Depression and Anxiety, 2024 - Wiley Online Library
Introduction. The use of antidepressant and anxiolytic drugs has changed in Scandinavian
countries over recent decades, with notable national variations. Objective. To describe and …